The global in vitro diagnostics market (IVD) was valued at $67,111 million in 2019, and is projected to reach $91,093 million at a CAGR of 4.8% from 2020 to 2027. For instance, in clinical chemistry ...

Further, the US with USD 41.8 billion market in 2023, holds majority share in the global In-vitro Diagnostics market and is likely to remain the leading region growing a CAGR of 5.0% within this ...

The FDA on Friday granted marketing authorization to the first at-home test for diagnosing chlamydia, gonorrhea, and ...

Countries in Africa are having to seek alternative funding amid a block to US funding for mpox response efforts.

Dublin, March 21, 2025 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostics - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global In Vitro Diagnostics (IVD ...

The FDA has cleared its first completely at-home sexual health test for women, available over-the-counter to screen for chlamydia, gonorrhea and trichomoniasis. | Visby's kit includes vaginal ...

Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation ... s Disease and Ulcerative Colitis Patients Biomerica’s food intolerance products use proprietary technology to identify ...

Global in vitro diagnostics (IVD) market will reach $148,393.3 million by 2031, growing by 6.3% annually over 2021-2031. The global in vitro diagnostics (IVD) market encompasses a wide range of ...

For over 30 years as a global leader in automated ID/AST systems, bioMérieux continues to collaborate with laboratory professionals and clinicians to innovate microbiology solutions for improved ...